 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Module Overview

What is your course about?

Who is the mini-course for?

Teaching goals (learners will be able to):

Extra keywords

Slide-by-Slide Presentation

SLIDE 1 — OPENING HOOK (45 sec)

SLIDE 2 — CONCEPT SIMPLIFIED (60 sec)

SLIDE 3 — CASE STUDY (90 sec)

SLIDE 4 — PRACTICAL APPLICATION (60 sec)

SLIDE 5 — KNOWLEDGE CHECK + TAKEAWAYS (45 sec)

Summaries and Checklists

10 Key Concepts Summary

10-Point Audit / Inspection Checklist

Part C — Top 5 Takeaways

Quiz

Part A — Quiz (5 scenario-based questions)

Survey

Part B — Reflection

Welcome to the comprehensive course on ICH Q3A(R2) Analytical Procedures for Impurity Detection and Quantitation. In the highly regulated pharmaceutical industry, robust impurity detection is paramount to protecting patient safety, ensuring product quality, and maintaining regulatory standing.

Welcome to the comprehensive course on ICH Q3A(R2) Analytical Procedures for Impurity Detection and Quantitation. In the highly regulated pharmaceutical industry, robust impurity detection is paramount to protecting patient safety, ensuring product quality, and maintaining regulatory standing. This specialized mini-course is meticulously designed to demystify the complexities of the ICH Q3A(R2) guidelines, focusing specifically on the analytical procedures required for accurate impurity detection and quantitation in drug substances. 

Throughout this course, you will explore the critical linkage between method transfer, routine reliability, and sustained compliance. We will dive deep into the underlying principles dictating that a method's limit of quantitation (LOQ) and limit of detection (LOD) must be commensurate with regulatory control thresholds. You will learn how to identify common industry warning signs, such as an LOQ above the reporting threshold or unlabeled unidentified impurities, and understand the risks associated with unvalidated method changes during analytical development.

By engaging with realistic case studies, including batch-release scenarios involving borderline impurity results, you will develop the skills to make sound, risk-based decisions under time pressure. The course also provides practical tools, including a 10-point audit and inspection checklist, to help you assess laboratory records for ICH Q3A(R2) compliance, detect uncorrected response-factor bias, and evaluate co-eluting peaks. Whether you are looking to refine your chromatography data review process or ensure your laboratory practices align perfectly with regulatory expectations, this course provides the actionable insights and foundational principles you need to succeed.

109. ICH Q3A(R2) Analytical Procedures for Impurity Detection and Quantitation

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The accurate detection and quantitation of impurities in drug substances are foundational to ensuring patient safety, product quality, and sustained regulatory compliance. Under the ICH Q3A(R2) guideline, analytical procedures must be meticulously designed and validated to demonstrate that their limits of quantitation (LOQ) and limits of detection (LOD) are commensurate with established regulatory thresholds, such as reporting, identification, and qualification limits. For quality assurance reviewers, quality control analysts, and regulatory affairs professionals, mastering these requirements is essential for defending impurity data and specifications during dossier submissions and regulatory inspections. This course provides a comprehensive examination of the principles governing impurity control, distinguishing between compliant and non-compliant laboratory practices while addressing the specific scope of what ICH Q3A(R2) dictates for drug substance impurities.</p>

<p>Through a structured progression of theoretical concepts, realistic batch-release case studies, and practical applications, learners will develop the critical skills necessary to navigate complex analytical challenges. The curriculum explores industry best practices, including response-factor correction conventions, the proper utilization of external impurity reference standards versus the drug substance, and robust system-suitability design. Furthermore, participants will be equipped with standardized inspection checklists and actionable takeaways to evaluate everyday laboratory practices, ensuring strict alignment with ICH Q3A(R2) Section 3.3.1. By bridging the gap between analytical development, routine reliability, and regulatory expectations, this training empowers cross-functional teams to make sound, risk-based decisions and maintain the highest standards of chromatographic data integrity.</p>
        </div>
    </div>
</div>
